论文部分内容阅读
胎儿娩出后24小时内产妇失血量超过500ml,临床上称为产后出血[1]。产后出血是全球孕产妇死亡的主要原因,每年全球约有15万名产妇死于产后出血[2],产后子宫收缩无力是产后出血的主要原因。因此选择不良反应少,安全有效,可以快速、高效止血的宫缩剂是治疗产后出血的关键。本文选取我院收治的60例孕产妇病例,对比分析缩宫素与卡贝缩宫素治疗产后出血的临床效果,报告如下。
Within 24 hours after delivery of the fetus, maternal blood loss over 500ml, clinically known as postpartum hemorrhage [1]. Postpartum hemorrhage is the leading cause of maternal mortality worldwide, with around 150,000 maternal deaths occurring in postpartum hemorrhage each year [2]. Postpartum uterine contractions are the leading cause of postpartum hemorrhage. Therefore, the choice of adverse reactions less, safe and effective, can quickly and efficiently hemostatic uterotonics is the key to treating postpartum hemorrhage. This article selected 60 cases of pregnant women admitted to our hospital, comparative analysis of oxytocin and carbetocin treatment of postpartum hemorrhage clinical effect, the report is as follows.